199 related articles for article (PubMed ID: 6257013)
21. Receptors for vasoactive intestinal peptide on isolated epithelial cells of rat ventral prostate.
Prieto JC; Carmena MJ
Biochim Biophys Acta; 1983 Dec; 763(4):408-13. PubMed ID: 6317051
[TBL] [Abstract][Full Text] [Related]
22. Cyclic AMP-stimulating effect of vasoactive intestinal peptide in isolated epithelial cells of rat ventral prostate.
Carmena MJ; Prieto JC
Biochim Biophys Acta; 1983 Dec; 763(4):414-8. PubMed ID: 6317052
[TBL] [Abstract][Full Text] [Related]
23. Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1.
Emami S; Gespach C; Forgue-Lafitte ME; Broer Y; Rosselin G
Life Sci; 1983 Aug; 33(5):415-23. PubMed ID: 6192308
[TBL] [Abstract][Full Text] [Related]
24. Decreased binding of vasoactive intestinal peptide to intestinal epithelial cells from hypothyroid rats.
Molinero P; Calvo JR; Jimenez J; Goberna R; Guerrero JM
Biochem Biophys Res Commun; 1989 Jul; 162(2):701-7. PubMed ID: 2547371
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
[TBL] [Abstract][Full Text] [Related]
26. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages.
Segura JJ; Guerrero JM; Goberna R; Calvo JR
Regul Pept; 1992 Feb; 37(3):195-203. PubMed ID: 1372999
[TBL] [Abstract][Full Text] [Related]
27. The vasoactive intestinal peptide receptor-effector system is developmentally regulated in rat jejuno-ileal epithelial cells.
Fernandez-Moreno MD; Diaz-Juarez JL; Fernandez-Gonzalez MA; Sanchez-Franco F; Prieto JC
Biochem Int; 1988 Feb; 16(2):331-7. PubMed ID: 2835052
[TBL] [Abstract][Full Text] [Related]
28. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
[TBL] [Abstract][Full Text] [Related]
29. Porcine peptide having N-terminal histidine and C-terminal isoleucine amide (PHI): vasoactive intestinal peptide (VIP) and secretin-like effects in different tissues from the rat.
Bataille D; Gespach C; Laburthe M; Amiranoff B; Tatemoto K; Vauclin N; Mutt V; Rosselin G
FEBS Lett; 1980 Jun; 114(2):240-2. PubMed ID: 6248367
[No Abstract] [Full Text] [Related]
30. Chronic ethanol intake inhibits both the vasoactive intestinal peptide binding and the associated cyclic AMP production in rat enterocytes.
Jimenez J; Calvo JR; Molinero P; Goberna R; Guerrero JM
Gen Pharmacol; 1992 Jul; 23(4):607-11. PubMed ID: 1327944
[TBL] [Abstract][Full Text] [Related]
31. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate.
Inoue Y; Kaku K; Kaneko T; Yanaihara N; Kanno T
Endocrinology; 1985 Feb; 116(2):686-92. PubMed ID: 2578385
[TBL] [Abstract][Full Text] [Related]
32. Vasoactive intestinal peptide stimulates androgen biosynthesis by cultured neonatal testicular cells.
Kasson BG; Lim P; Hsueh AJ
Mol Cell Endocrinol; 1986 Nov; 48(1):21-9. PubMed ID: 2430845
[TBL] [Abstract][Full Text] [Related]
33. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
Gespach C; Hui Bon Hoa D; Rosselin G
Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
[TBL] [Abstract][Full Text] [Related]
34. Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.
Camilleri M; Cooper BT; Adrian TE; Bloom SR; Chadwick VS
Gut; 1981 Jan; 22(1):14-8. PubMed ID: 6257593
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrum.
Gespach C; Bataille D; Dupont C; Rosselin G; Wünsch E; Jaeger E
Biochim Biophys Acta; 1980 Jul; 630(3):433-41. PubMed ID: 6249385
[TBL] [Abstract][Full Text] [Related]
36. Cyclic AMP production in isolated colonic epithelial crypts: a highly sensitive model for the evaluation of vasoactive intestinal peptide action in human intestine.
Dupont C; Laburthe M; Broyart JP; Bataille D; Rosselin G
Eur J Clin Invest; 1980 Feb; 10(1):67-76. PubMed ID: 6245891
[No Abstract] [Full Text] [Related]
37. VIP interaction with intestinal epithelial cells and liver plasma membranes from hepatectomized rats.
Prieto JC; Diaz-Juarez JL; Arilla E
Peptides; 1986; 7 Suppl 1():273-8. PubMed ID: 3018701
[TBL] [Abstract][Full Text] [Related]
38. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.
Waelbroeck M; Robberecht P; De Neef P; Chatelain P; Christophe J
Biochim Biophys Acta; 1981 Nov; 678(1):83-90. PubMed ID: 6272875
[TBL] [Abstract][Full Text] [Related]
39. Cyclic AMP in pancreatic acinar cells: effects of gastrointestinal hormones.
Gardner JD; Conlon TP; Adams TD
Gastroenterology; 1976 Jan; 70(1):29-35. PubMed ID: 173615
[TBL] [Abstract][Full Text] [Related]
40. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
Birnbaum RS; Alfonzo M; Kowal J
Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
